Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Margolin

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Shortening the infusion time of anticancer drugs: who will benefit?Kim Margolin, Michael Gordon
Cancers|November 12, 2013
Cytokines in cancer immunotherapySylvia Lee, Kim Margolin
Seminars in Oncology|October 31, 2002
The treatment of brain metastases from malignant melanomaJames G Douglas, Kim Margolin
Cancer|March 1, 2014
Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanomaPaolo A Ascierto, Kim Margolin
Cancer Discovery|May 3, 2019
Metabolic Checkpoint of Immune Cells in Melanoma Brain MetastasesColt A Egelston, Kim Margolin
Therapeutic Advances in Medical Oncology|December 18, 2015
Long-term survival as a treatment benchmark in melanoma: latest results and clinical implicationsKenneth F Grossmann, Kim Margolin
Hematology/Oncology Clinics of North America|March 6, 2019
Cytokine TherapyAnn W Silk, Kim Margolin
Cancer|April 8, 2011
Melanoma's deadly march to the brain: by what route, and can it be stopped?Megan Othus, James Moon, Kim Margolin
Seminars in Oncology|May 13, 2015
Immune checkpoint blockade in patients with melanoma metastatic to the brainAnna Maria Di Giacomo, Kim Margolin
The New England Journal of Medicine|November 29, 2018
Nivolumab and Ipilimumab in Melanoma Metastatic to the BrainHussein A Tawbi, Caroline Chung, Kim Margolin
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Shortening the infusion time of anticancer drugs: who will benefit?Kim Margolin, Michael Gordon
Cancers|November 12, 2013
Cytokines in cancer immunotherapySylvia Lee, Kim Margolin
Seminars in Oncology|October 31, 2002
The treatment of brain metastases from malignant melanomaJames G Douglas, Kim Margolin
Cancer|March 1, 2014
Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanomaPaolo A Ascierto, Kim Margolin
Cancer Discovery|May 3, 2019
Metabolic Checkpoint of Immune Cells in Melanoma Brain MetastasesColt A Egelston, Kim Margolin
Therapeutic Advances in Medical Oncology|December 18, 2015
Long-term survival as a treatment benchmark in melanoma: latest results and clinical implicationsKenneth F Grossmann, Kim Margolin
Hematology/Oncology Clinics of North America|March 6, 2019
Cytokine TherapyAnn W Silk, Kim Margolin
Cancer|April 8, 2011
Melanoma's deadly march to the brain: by what route, and can it be stopped?Megan Othus, James Moon, Kim Margolin
Seminars in Oncology|May 13, 2015
Immune checkpoint blockade in patients with melanoma metastatic to the brainAnna Maria Di Giacomo, Kim Margolin
The New England Journal of Medicine|November 29, 2018
Nivolumab and Ipilimumab in Melanoma Metastatic to the BrainHussein A Tawbi, Caroline Chung, Kim Margolin
Pageof 10